Northwest Biotherapeutics (NWBO) Short-term Investments (2014 - 2017)

Northwest Biotherapeutics' Short-term Investments history runs 4 years deep, the most recent figure standing at $397000.0 for Q1 2017.

• On a quarterly basis, Short-term Investments fell 46.78% year-over-year to $397000.0 in Q1 2017; TTM through Mar 2017 was $397000.0, a 46.78% decrease from a year earlier, with the FY2016 full-year figure at $685000.0, down 22.69% from the prior year.
• Short-term Investments fell to $397000.0 in Q1 2017 per NWBO's latest filing, from $685000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $1.0 million in Q2 2015 and bottomed at $397000.0 in Q1 2017.
• The 4-year median for Short-term Investments is $806000.0 (2014), against an average of $779400.0.
• Across the five-year window, Short-term Investments increased 2.43% in 2015 and slumped 46.78% in 2017, its largest moves.
• Year by year, Short-term Investments stood at $865000.0 in 2014, then climbed by 2.43% to $886000.0 in 2015, then slipped by 22.69% to $685000.0 in 2016, then tumbled by 42.04% to $397000.0 in 2017.
• Per Business Quant, the three latest NWBO Short-term Investments figures stand at $397000.0 (Q1 2017), $685000.0 (Q4 2016), and $685000.0 (Q3 2016).